The Impact Of Art On Wellbeing In Autoimmune Disease PDF Print E-mail
Tuesday, 25 October 2011 09:11
taken from http://www.flickr.com/photos/georgiap/2230846846/ via creative commonsAn innovative Newcastle research project is measuring the impact of creating art on the symptoms and overall wellbeing of people living with an autoimmune illness.

A team at the University of Newcastle, in conjunction with the Autoimmune Resource and Research Centre at John Hunter Hospital, is working with participants with a range of autoimmune illnesses including Lupus, Scleroderma, Rheumatoid Arthritis and Sjögren's syndrome. Dr Kathryn Grushka from the University said the team was monitoring improvements to participants’ sense of wellbeing and measureable indicators of health, particularly levels of stress.

“Stress is a major flare factor for autoimmune illnesses. We are testing levels of the stress hormone cortisol by taking saliva samples before and after artmaking workshops,” Dr Grushka said.

Participants’ quality of life and functionality is being measured by reviewing digital and written diaries and through standard health assessments, such as testing mobility, blood pressure and heart rate.

The study consists of artists, non-artists and those without an autoimmune illness, with all participants asked to produce artworks based on personal experiences. The results are due to be published in early 2012.

Work created through the project will be displayed in the halls of John Hunter Hospital from Tuesday 4 October, Lupus awareness month, until January 2012 as part of Hunter New England Health’s ‘Arts for Health Program’.

 
More articles :

» Promedior Announces Publication of New Research Demonstrating Pentraxin-2/SAP is a Potent Inhibitor of Pulmonary Fibrosis

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology...

» Understanding More About Your Rheumatoid Arthritis

Arthritis is inflammation of one or more joints. The main symptoms of arthritis are joint pain and stiffness, which typically worsens with age. The two most common types of arthritis are osteoarthritis and rheumatoid arthritis.Osteoarthritis is...

» Lower Extremity Ulcers in Systemic Sclerosis: Features and Response to Therapy

Victoria K. Shanmugam, MBBS, MRCP; Patricia Price, PhD; Christopher E. Attinger, MD; Virginia D. Steen, MD Non-digital lower extremity ulcers are a difficult to treat complication of scleroderma that is often refractory to therapy. They are a...

» Shyanne Adams Heading To London Courtesy Of The Make-A-Wish Foundation

It wasn't until Shyanne Adams started feeling better recently that she realized just how hard the past year has been. “I think I was in shock the whole year,” said the 14-year-old Eagle Valley Middle School eighth-grader. “I was depressed. I...

» Interleukin-6: A New Therapeutic Target in Scleroderma

Interleukin-6 (IL-6) is a classic pro-inflammatory cytokine critical in mounting an effective immune response. It is secreted by a wide array of cell types; however, its effector cells are more restricted, owing to the fact that very few cells,...

» Long-Term Outcomes of Scleroderma Renal Crisis

In a previous study. researchers sought to describe the medical history of a group of patients with Scleroderma Renal Crisis who had been treated with ACE inhibitors. The following is essentially a summary of that study, which was conducted by...